Lymphomatosis cerebri (LC) is a rare form of primary central nervous system lymphoma (PCNSL). Little is known about cases of LC with spinal cord involvement. Among the 11 PCNSL patients treated in our hospital during a four-year period, we identified two cases of LC with spinal cord lesions. One showed a spinal cord lesion followed by leukoencephalopathy. The other showed a spinal cord lesion after LC. In both cases, the histopathology was diffuse large B-cell lymphoma. It is possible that LC may affect the entire central nerve system, and tumor infiltration to the brain and spinal cord in LC may occur more frequently than has been previously considered.
Introduction
Primary central nervous system lymphoma (PCNSL) is a rare variant of extranodal non-Hodgkin's lymphoma that is confined to the eyes, brain, leptomeninges and spinal cord. The most common radiological finding of PCNSL in immunocompetent patients is a single lesion or multiple focal lesions with homogeneous contrast enhancement (1-3). Lymphomatosis cerebri (LC) is an exceedingly rare variant of PCNSL characterized by the diffuse infiltration of lymphoma cells, and its presentation on magnetic resonance imaging (MRI) shows diffuse leukoencephalopathy with only mild or absent contrast enhancement (4, 5) . LC is associated with no specific MRI features; therefore, physicians sometimes fail to distinguish LC from other causes of leukoencephalopathy. In addition, intramedullary spinal cord lymphoma is extremely rare (6, 7) , and little is known about the clinical features of LC accompanied by intramedullary spinal cord involvement. The histopathological findings of several autopsied cases of PCNSL showed a widespread appearance with spinal cord involvement (8) . Although the pathological findings of these autopsied cases suggest that spinal cord involvement is occasionally found in patients with PCNSL, the reports of LC concomitant with MRIconfirmed spinal cord involvement are scarce. We herein report two patients with LC accompanied by intramedullary spinal cord lesions. The radiological and clinical findings of these two patients present a diagnostic dilemma of isolated intramedullary spinal cord lesions, and suggest that tumor infiltration between the spinal cord and brain may occasionally appear in patients with LC. hyperintense lesion on T2-weighted images with gadolinium contrast enhancement (Fig. 1A, G) . Spinal cord biopsy specimens obtained four months after onset showed nondiagnostic histopathological findings. Five months after the initial symptoms, brain MRI showed diffuse hyperintense lesions in the cerebral white matter, bilateral internal capsules, splenium and brainstem on fluid-attenuated inversion recovery (FLAIR) images without gadolinium contrast enhancement (Fig. 1B, C, H, I ). As a decline in cognitive function began seven months after the initial symptoms, he was referred to our department. On examination, he showed mild cognitive impairment, paresis of the right arm and spastic paralysis of the left leg. The diffuse infiltrating lesions in the white matter had expanded, and a contrast-enhancing lesion appeared in the frontal white matter and splenium (Fig. 1D, J) ; however, the gadolinium-enhancing spinal cord lesion was diminished, and slight atrophy had developed in the spinal cord (Fig. 1E, K) . Laboratory findings, including the serum lactate dehydrogenase (LDH) and soluble interleukin-2 receptor (sIL-2R) levels, were within the normal range. Anti-nuclear and anti-aquaporin-4 antibodies were negative. There was no evidence of infectious disease, sarcoidosis, inflammatory disease or malignant disease on systemic investigation. Furthermore, the autoantibodies associated with paraneoplastic neurological syndrome (anti-HuD, Yo, Ri, CRMP5, amphiphysin, Ma1, M2) were not detected by a Western blot analysis (ravo PNS Blot; ravo Diagnostika GmbH, Freiberg, Germany).
A cerebrospinal fluid (CSF) examination showed an increased protein level (100 mg/dL) with pleocytosis (cell count of 30/μL); however, B-cell malignancy was not detected on repeated cytology, flow cytometry or in the analyses of clonally rearranged immunoglobulin heavy-chain genes. The oligoclonal band was negative. Although gadolinium-enhancing lesions of the splenium are frequently observed in PCNSL, we could not exclude the possibility of steroid-responsive inflammatory diseases. High-dose corticosteroid therapy initially ameliorated his symptoms, but his condition gradually worsened despite repeated high-dose administration of corticosteroids.
To obtain a definitive diagnosis, a brain biopsy of the gadolinium-enhancing lesion in the frontal lobe was performed. The neuropathological findings showed scattered infiltration of atypical cells, with enlarged irregularly-shaped nucleoli ( Fig. 2A) . Mitotic cells were also present. An immunohistochemical examination showed that the atypical cells were positive for CD20 (Fig. 2B) . The pathological diagnosis was therefore diffuse large B-cell lymphoma 
(DLBCL).
The patient underwent chemotherapy and irradiation of the whole brain and spinal cord. His cognitive function and paresis of the right arm partially improved. A subsequent brain MRI showed shrinkage of the hyperintense lesions on brain FLAIR images and the disappearance of gadoliniumenhancing lesions (Fig. 1F, L) . After treatment, his remission has persisted for more than two years.
Case 2
A 45-year-old immunocompetent woman presented with a two-month history of headache and vertigo. Brain MRI showed diffuse hyperintense lesions in the cerebral white matter, bilateral internal capsules, brainstem and cerebellar peduncle on FLAIR images (Fig. 3A, B) . Gadoliniumenhancing lesions were also present within the diffuse hyperintense lesions of the white matter and the cerebellar peduncles (Fig. 3G, H ). An intramedullary spinal cord lesion was not found on spinal cord MRI. The serum LDH and sIL-2R levels were within the normal range. There was no evidence of infection, sarcoidosis, malignant disease or other inflammation during a systemic investigation. The CSF examination showed an increased protein level (45 mg/dL) with pleocytosis (cell count of 23/μL). The oligoclonal band was negative. Although high-dose corticosteroid therapy initially ameliorated her symptoms, subsequent disturbances in consciousness rapidly appeared two weeks after corticosteroid treatment. She was then referred to our hospital, and a brain biopsy was performed. The neuropathological diagnosis was DLBCL.
The patient underwent whole brain irradiation, and her symptoms gradually improved. The gadolinium-enhanced lesions almost completely disappeared and the FLAIR hyperintense lesions were partially reduced (Fig. 3C, D, I , J). Although her brain lesions were improved, she subsequently developed left paresis. Spinal cord MRI showed a hyperintense lesion on T2-weighted images with gadolinium contrast enhancement (Fig. 3E, K) . After spinal cord irradiation, the left paresis was improved and the spinal cord lesion had mostly disappeared (Fig. 3F, L) . She additionally underwent chemotherapy with methotrexate. She had a relapse in the spinal cord eight months after the initial symptoms and was treated with high-dose chemotherapy following autologous peripheral blood stem cell transplantation. After the treatment, remission has persisted for more than four years.
Discussion
We herein presented two cases of LC accompanied by intramedullary spinal cord lesions. The clinical and radiological features of Case 1 included that the patient initially showed myelopathy caused by an isolated intramedullary spinal cord lesion. The incidence of intramedullary lymphoma is exceedingly rare (6, 7, 9) . Furthermore, isolated spinal cord involvement is uncommon and observed in <1% of cases of PCNSL (3) . As the MRI findings of primary intramedullary spinal cord lymphoma (PISCL) mimic those of other causes of myelopathy, including demyelinating disease, Flanagan et al. described the characteristic MRI features of PISCL as follows: 1) multifocal, 2) persistent gadolinium-enhancement and 3) cauda equina or conus medullaris involvement (7). Moreover, CSF findings of markedly elevated protein levels (>100 mg/dL), a lack of oligoclonal bands and an elevated cell count were also proposed as diagnostic clues, because they discriminate lymphoma from multiple sclerosis (7). The preceding spinal cord lesion in Case 1 regressed spontaneously, and this might have complicated the early diagnosis and delayed appropriate therapy. Alderson et al. reported four cases of contrastenhanced brain lesions with variable but non-diagnostic histopathological findings that preceded the pathological diagnosis of PCNSL by several months, They called such preceding lesions 'sentinel lesions' (10). We could not fully conclude whether the spinal cord lesion in Case 1 was a 'sentinel lesion'. However, our case progressively deteriorated without a remission, which was typically seen in other cases with sentinel lesions.
A relationship between an intramedullary spinal cord le- sion and cerebral diffuse tumor cell infiltration also was noted in Case 2. Although the pathology of the spinal cord lesion remains unknown, the good response to radiation therapy suggested that it was a malignant tumor, rather than a demyelinating lesion (11) . The route of tumor infiltration in these cases remains unclear. Two routes of tumor metastasis have been speculated: one is direct intraparenchymal invasion, and the other is dissemination via the CSF (8) . Intraparenchymal invasion may have occurred in our patients, although signal changes visible on MRI were not detected. Alternatively, CSF pleocytosis was found in our patients, representing one of the possible aspects of meningeal dissemination (12); however, we failed to detect evidence of tumor meningeal dissemination. Nevertheless, our findings and those of recent studies suggest that central nerve system (CNS) lymphoma may be a whole brain disease, despite the fact that it presents as a solid mass in one or more locations. The clinical and radiological findings of our current patients indicate that patients with leukoencephalopathy or an isolated intramedullary spinal cord lesion of unknown etiology should be considered to have possible CNS lymphoma, representing a disease of the whole CNS. We also reviewed the radiological and clinical findings of a series of 11 consecutive immunocompetent patients with PCNSL treated in our hospital from 2008 to 2011 (unpublished data). All pathological diagnoses were DLBCL, and radiological findings of cerebral diffuse white matter lesions were confirmed in three cases (Case 1, Case 2, and a case not presented here). Among the three patients with PCNSL, two (Cases 1 and 2) showed MRI-confirmed intramedullary spinal cord involvement. Based on these clinical and radiological findings, it is possible that tumor infiltration between the spinal cord and brain may occur in the course of the disease process in LC, and that the frequency of these findings may be relatively higher than has been previously considered.
In conclusion, we herein presented two cases of LC with intramedullary spinal cord involvement. Further studies involving larger numbers of patients with PCNSL accompanied by intramedullary spinal cord lesions are needed to clarify their clinical and radiological features. Physicians should be aware that LC may be a differential diagnosis of leukoencephalopathy, and should be treated as a disease of the whole CNS with spinal cord involvement.
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